Skip to main content
Log in

A Japanese Family of Spinocerebellar Ataxia Type 21: Clinical and Neuropathological Studies

  • Original Paper
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

Spinocerebellar ataxia type 21 (SCA21) is a rare subtype of autosomal dominant cerebellar ataxias, which was first identified in a French family and has been reported almost exclusively in French ancestry so far. We here report the first Japanese family with SCA21, in which all affected members examined carried a heterozygous c.509C > T:p.Pro170Leu variant in TMEM240. Their clinical features were summarized as a slowly progressive ataxia of young-adult onset (5–48 years) associated with various degree of psychomotor retardation or cognitive impairment. The MR images revealed atrophy in the cerebellum, but not in the cerebrum or brainstem. These clinical findings were consistent with those in the original French families with SCA21. Neuropathological findings in one autopsied patient showed a prominent decrease of cerebellar Purkinje cells, but no specific abnormalities outside the cerebellum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Delplanque J, Devos D, Huin V, Genet A, Sand O, Moreau C, et al. TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment. Brain. 2014;137:2657–63. https://doi.org/10.1093/brain/awu202.

    Article  PubMed  Google Scholar 

  2. Zeng S, Zeng J, He M, Zeng X, Zhou Y, Liu Z, et al. Spinocerebellar ataxia type 21 exists in the Chinese Han population. Sci Rep. 2016;6:19897. https://doi.org/10.1038/srep19897.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.

    Article  PubMed  CAS  Google Scholar 

  4. Mizuguchi T, Nakashima M, Kato M, Yamada K, Okanishi T, Ekhilevitch N, et al. PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder. J Hum Genet. 2017;62:525–9. https://doi.org/10.1038/jhg.2016.163.

    Article  PubMed  CAS  Google Scholar 

  5. Devos D, Schraen-Maschke S, Vuillaume I, Dujardin K, Nazé P, Willoteaux C, et al. Clinical features and genetic analysis of a new form of spinocerebellar ataxia. Neurology. 2001;56:234–8.

    Article  PubMed  CAS  Google Scholar 

  6. Delplanque J, Devos D, Vuillaume I, De Becdelievre A, Vangelder E, Maurage CA, et al. Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21). Cerebellum. 2008;7(2):179–83. https://doi.org/10.1007/s12311-008-0014-3.

    Article  PubMed  CAS  Google Scholar 

  7. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Satake T, Yamashita K, Hayashi K, Miyatake S, Tamura-Nakano M, Doi H, et al. MTCL1 plays an essential role in maintaining Purkinje neuron axon initial segment. EMBO J. 2017;36:1227–42. https://doi.org/10.15252/embj.201695630.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Ms. Misuzu Netsu for her technical assistance on neuropathological examinations.

Funding

This work was supported from Research Committee of the Ataxia, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (MHLW), Japan (Yoshida K), the grants for Research on Measures for Intractable Diseases grant (Matsumoto N); the Comprehensive Research on Disability Health and Welfare grant (Matsumoto N); the Strategic Research Program for Brain Science (Matsumoto N); the Practical Research Project for Rare/Intractable Diseases (Matsumoto N), from the Japan Agency for Medical Research and Development (AMED); a grant-in-aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); grants-in-aid for Scientific Research (A, and C) (Matsumoto N, Doi H, Miyatake S); the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency (JST) (Matsumoto N); and grants from the Ministry of Health, Labor and Welfare (MHLW), Japan (Matsumoto N), grant provided by The Ichiro Kanehara Foundation (Miyatake S), and the Takeda Science Foundation (Matsumoto N).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kunihiro Yoshida.

Ethics declarations

Written informed consent was obtained from all the individuals and molecular analyses were approved by the Committee for Ethical Issues at both Shinshu University School of Medicine and Yokohama City University School of Medicine.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yahikozawa, H., Miyatake, S., Sakai, T. et al. A Japanese Family of Spinocerebellar Ataxia Type 21: Clinical and Neuropathological Studies. Cerebellum 17, 525–530 (2018). https://doi.org/10.1007/s12311-018-0941-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-018-0941-6

Keywords

Navigation